Increase in Osteocalcin Following Testosterone Therapy in Men With Type 2 Diabetes and Subnormal Free Testosterone.
Husam GhanimSandeep DhindsaKelly GreenSanaa AbuayshehManav BatraAntoine MakdissiAjay ChaudhuriParesh DandonaPublished in: Journal of the Endocrine Society (2019)
We conclude that testosterone replacement resulted in an increase in osteocalcin and a transient increase in CTx, indicating an increase in osteoblastic activity and transient increase in bone breakdown. Therefore, a major action of testosterone is to increase bone turnover in men with type 2 diabetes.